Results 41 to 50 of about 161,421 (304)

Apixaban for the prevention of thromboembolism in adults after elective hip or knee replacement surgery, and in symptomatic venous thromboembolism [PDF]

open access: yes, 2012
The anticoagulant effect of apixaban is due to direct inhibition of FXa in the coagulation cascade. The main advantages apixaban has over the current anti-coagulant drugs is that it is active after oral administration, and its coagulation effect does not
Doggrell, Sheila
core   +1 more source

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

open access: yesArthritis Care &Research, EarlyView.
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram   +25 more
wiley   +1 more source

Partial Purification and Biochemical Evaluation of Protease Fraction (MA-1) from Mycoleptodonoides aitchisonii and Its Fibrinolytic Effect

open access: yesAntioxidants, 2023
The antioxidative proteolytic fraction, MA-1, was partially purified from Mycoleptodonoides aitchisonii. MA-1 was purified to homogeneity using a two-step procedure, which resulted in an 89-fold increase in specific activity and 42.5% recovery.
Sung-Ho Lee   +8 more
doaj   +1 more source

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

open access: yesArthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin   +7 more
wiley   +1 more source

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Cases of thromboembolic events in 2021 flared up the discussion about the safety of Astra Zeneca’s AZD1222 vaccine. We hereby report three cases of pulmonary embolism (PE), one case of extended portal vein thrombosis, and one case of combined portal vein
Sascha d’Almeida   +11 more
doaj   +1 more source

Thromboembolism and the Pandemic

open access: yesJournal of the American College of Cardiology, 2020
[Figure: see text]
openaire   +2 more sources

Rheumatoid arthritis, frailty, and outcomes of surgical hospitalizations: A national population‐based analysis

open access: yesArthritis Care &Research, Accepted Article.
OBJECTIVE Hospitalization, particularly for surgery, represents a period of heightened stress. We evaluated how frailty attenuates the association of rheumatoid arthritis (RA) with negative health outcomes after elective non‐cardiac surgery. METHODS We conducted a cross‐sectional study using the National Inpatient Sample (2018 to 2020), including ...
Ali Yazdanyar   +5 more
wiley   +1 more source

Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) - Venous Thromboembolism in Neurocritical Care Patients

open access: yes, 2019
Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748)   +7 more
core   +1 more source

Real‐World Safety of Concomitant Colchicine and Statin Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan   +5 more
wiley   +1 more source

Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 - Venous Thromboembolism in Neurocritical Care Patients

open access: yes, 2019
Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy